Kristen Ebbehøj

Title: Kristen Ebbehøj: Innovator in Pharmaceutical Formulations

Introduction

Kristen Ebbehøj is a notable inventor based in Nærum, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of human growth hormone. Her innovative work has led to the development of a unique aqueous pharmaceutical formulation that enhances the efficacy of treatments.

Latest Patents

Kristen holds 1 patent for her invention related to pharmaceutical formulations. This patent specifically involves an aqueous formulation comprising human growth hormone, histidine, poloxamer, phenol, and mannitol. This formulation is designed to improve the stability and delivery of the hormone, making it a valuable advancement in medical treatments.

Career Highlights

Kristen is currently employed at Novo Nordisk Healthcare AG, a leading global healthcare company specializing in diabetes care and other chronic conditions. Her role at Novo Nordisk has allowed her to work on cutting-edge research and development projects that aim to improve patient outcomes.

Collaborations

Throughout her career, Kristen has collaborated with esteemed colleagues such as Søren Bjørn and Hans Holmegaard Sørensen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kristen Ebbehøj's contributions to pharmaceutical formulations exemplify her dedication to advancing healthcare solutions. Her innovative spirit and collaborative efforts continue to make a significant impact in the field.